MoFo BioMeter – Vol. 3, Issue 3, August 2014 – Q2 Biometer Shows Strong Value In Drug Discovery Platforms

The average BioMeter value in the second quarter of 2014 jumped significantly to $143.4 million, an increase from the $15.9 million value in the first quarter. This included two blockbuster deals, the $1 billion up front paid by Merck to Bayer for…
By: Morrison & Foerster LLP